This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Mtm Laboratories, Ag, Roche Mtm Laboratories Ag. Active years: 2011-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2014
Title: Innovations in Cancer Treatment by Inventor Stefan Woerner
Introduction
Stefan Woerner is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of cancer detection and treatment through his innovative research and patented inventions. With a focus on disorders associated with frameshift mutations, his work aims to improve diagnostic and therapeutic methods for various types of cancer.
Latest Patents
Stefan Woerner holds 2 patents related to compounds and methods useful for the detection and treatment of cancer. His first patent involves compounds and methods that target disorders associated with frameshift mutations in coding microsatellite regions. This invention is particularly applicable to cancers, especially those related to DNA mismatch repair deficient (MMR) sporadic tumors and hereditary nonpolyposis colorectal cancer (HNPCC). The methods described include immunotherapy techniques that utilize combinatorial mixtures of tumor-specific frameshift peptides to elicit a cytotoxic T-cell response against tumor cells.
His second patent also focuses on neopeptides and methods for cancer detection and treatment, emphasizing similar applications in diagnosing and treating disorders linked to frameshift mutations. The diagnostic methods aim to assess disorders associated with frameshift polypeptides by detecting immunological entities in body fluids. This innovative approach holds promise for both prevention and curative treatment of cancers and precancers.
Career Highlights
Throughout his career, Stefan Woerner has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with Roche Mtm Laboratories AG and Mtm Laboratories AG, where he contributed to advancements in cancer research and treatment methodologies.
Collaborations
Stefan has collaborated with esteemed colleagues in his field, including Johannes Gebert and Michael Linnebacher. Their joint efforts have furthered the understanding and development of innovative cancer therapies.
Conclusion
Stefan Woerner's contributions to cancer research through his patented inventions highlight the importance of innovation in medical science. His work not only enhances diagnostic capabilities but also paves the way for more effective treatment options for patients suffering from cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile